CLINICAL_TRIALS
trial_result
· 2013-05-10
Clinical Trial Update: A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer [Phase 2]
Summary
Phase 2 study of capecitabine (Xeloda) in locally advanced or metastatic breast cancer has completed and results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-05-10